Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

NCT02474368 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Head and Neck Carcinoma
Head and Neck Cancer Metastatic
Head or Neck Cancer

Interventions

RADIATION: Intensity Modulated Radiation Therapy (IMRT)
DRUG: Cisplatin
RADIATION: Stereotactic Body Radiotherapy (SBRT)

Sponsor

Dana-Farber Cancer Institute